{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1383670319106973186.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"R. Alan B. Ezekowitz"}],"foaf:familyName":[{"@value":"Ezekowitz"}],"foaf:givenName":[{"@value":"R. Alan B."}]}],"career":[{"institution":{"notation":[{"@value":"From the Laboratory of Developmental Immunology, Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, MA; the Department of Chemistry, Graduate School of Science, Osaka University, Toyonaka, Osaka, Japan; and the Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1363670319106973184","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1182/blood-2005-02-0530"},{"@type":"URI","@value":"http://ashpublications.org/blood/article-pdf/106/7/2551/1635071/zh801905002551.pdf"},{"@type":"PMID","@value":"15956276"}],"notation":[{"@value":"Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1182/blood-2005-02-0530_WMqmkzq0BWse1AfkExJIrXNaBLL"},{"@type":"OPENAIRE","@value":"doi_dedup___::f9c3724b8416aa89faea099c162b8082_WMqmkzq0BWse1AfkExJIrXNaBLL"}]}